1 documents found
Information × Registration Number 0307U003467, 0105U002090 , R & D reports Title Multicenter, double-blind, , double-dummy, randomized parallel group study to evaluate the safety and efficacy of 0,030 mg ethinylestradiol / 2 mg dienogest for 6 treatment cycles in female patients with acne papulopustulosa in comparison to 0,035 mg ethinylestradiol / 2 mg cyproterone acetate and placebo. popup.stage_title Мультіцентрове, подвійне сліпе, подвійне імітоване, рандомізоване дослідження, які проводяться у жінок з папуло-пустульозними угрями. Head Andrashko Yurij Volodymyrovych, Registration Date 23-03-2007 Organization Uzhgorod National University popup.description2 The results of the investigation gave a possibility to offer an approach to the treatment of acne-prone skin in women through adequate gormone correction.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Multicenter, double-blind, , double-dummy, randomized parallel group study to evaluate the safety and efficacy of 0,030 mg ethinylestradiol / 2 mg dienogest for 6 treatment cycles in female patients with acne papulopustulosa in comparison to 0,035 mg ethinylestradiol / 2 mg cyproterone acetate and placebo.
Head: Andrashko Yurij Volodymyrovych. Multicenter, double-blind, , double-dummy, randomized parallel group study to evaluate the safety and efficacy of 0,030 mg ethinylestradiol / 2 mg dienogest for 6 treatment cycles in female patients with acne papulopustulosa in comparison to 0,035 mg ethinylestradiol / 2 mg cyproterone acetate and placebo.. (popup.stage: Мультіцентрове, подвійне сліпе, подвійне імітоване, рандомізоване дослідження, які проводяться у жінок з папуло-пустульозними угрями.). Uzhgorod National University. № 0307U003467
1 documents found

Updated: 2026-03-24


Роздрукувати цю сторінку